XTL Biopharma Grants Exclusive Sublicense to Biossil Inc.
Ticker: XTLB · Form: 6-K · Filed: Mar 4, 2025 · CIK: 1023549
| Field | Detail |
|---|---|
| Company | Xtl Biopharmaceuticals Ltd (XTLB) |
| Form Type | 6-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sublicense, agreement, biotechnology
TL;DR
XTL Bio just inked a perpetual, royalty-free sublicense deal with Biossil Inc. for worldwide rights.
AI Summary
On March 4, 2025, XTL Biopharmaceuticals Ltd. entered into a definitive Exclusive Sublicense Agreement with Biossil Inc. Under this agreement, XTL will grant Biossil a royalty-free, exclusive, worldwide perpetual sublicense, including the right to sublicense, for the term of the agreement.
Why It Matters
This sublicense agreement could potentially expand the reach and commercialization of XTL's technology through Biossil's global network.
Risk Assessment
Risk Level: medium — The long-term success and financial implications of this sublicense are not yet fully detailed, introducing a degree of uncertainty.
Key Players & Entities
- XTL Biopharmaceuticals Ltd. (company) — The company filing the report and granting the sublicense.
- Bióssil Inc. (company) — The Canadian company receiving the exclusive sublicense.
- March 4, 2025 (date) — The date the Exclusive Sublicense Agreement was announced.
FAQ
What specific technology or intellectual property is being sublicensed by XTL Biopharmaceuticals to Biossil Inc.?
The filing does not specify the exact technology or intellectual property being sublicensed, only that an Exclusive Sublicense Agreement has been entered into.
What is the duration of the Exclusive Sublicense Agreement between XTL Biopharmaceuticals and Biossil Inc.?
The agreement grants a perpetual sublicense, indicating it has no fixed end date.
Does Biossil Inc. have the right to further sublicense the rights granted by XTL Biopharmaceuticals?
Yes, the agreement explicitly states that Biossil Inc. has the right to sublicense.
Are there any royalty payments involved for XTL Biopharmaceuticals from this sublicense agreement?
No, the sublicense granted to Biossil Inc. is royalty-free for XTL Biopharmaceuticals.
Under which jurisdiction is Biossil Inc. incorporated?
Bióssil Inc. is incorporated under the laws of Canada.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 4, 2025 regarding XTL BIOPHARMACEUTICALS LTD (XTLB).